[December 03, 2014]

Research and Markets: Global Sexually Transmitted Diseases (STDs) Testing Market 2013-2020 Disease Types, Testing Volume & Testing Devices Analysis of the $167 Billion Industry

Research and Markets (http://www.researchandmarkets.com/research/rkvk3q/global_sexually) has announced the addition of the "Global Sexually Transmitted Diseases (STDs) Testing Market (Disease Types, Testing Volume, Testing Devices and Geography) - Industry Analysis and Forecast, 2013 - 2020" report to their offering.

The diagnostic testing market for sexually transmitted diseases is forecast to reach $167.4 billion by 2020, registering a CAGR of 8.5% during 2014-2020.

The growth in the market is chiefly attributed to the high growth in HIV and HPV testing, especially in Asia Pacific and African regions along with complementing growth rate of the European market.

Laboratory testing of STDs is significant, despite the presence of many Point-of-Care (PoC) testing kits available. Some of the STDs are not diagnosed with Point-of-Care methods. For instance, HSV (Herpes Simplex Virus), low-risk HPV (Human Papilloma Virus) and Chancroid, that manifest as "warts" on the patient's skin, require physical examination by the laboratory experts. Also, many of the PoC devices are not yet approved by the regulatory health authorities such as USFDA, owing to deviations in the sensitivity and specificity criteria. For these reasons, laboraory testing is considered to be the most reliable and globally accepted method for STD testing; therefore, it garners a comparatively larger market share than POC testing.

The report also provides market size and forecast for testing devices used for carrying such tests. The market for STD testing devices was valued at $7.7 billion in 2013, with laboratory testing devices accounting for most of the market, and PoC devices shall grow at the fastest rate.

Key findings of the study:

• Global market for diagnostic testing of STDs is gaining traction with growth in HIV and HPV screening and laboratory testing
• HIV testing market segment would grow at a CAGR of 10.9% during the forecast period
• Europe would be one of the lucrative markets in terms of growth. The European STDs testing market would reach $26.8 billion by 2020, with highest CAGR of 13.5% (as compared to other regional markets)
• HPV testing volume and revenue will grow at much faster rate owing to higher incidences in Asia Pacific region

Scope of the Report

MARKET BY SEXUALLY TRANSMITTED DISEASE TYPES

• Chlamydia testing
• Syphilis testing
• Gonorrhoea testing
• Herpes Simplex Virus testing
• Human Papilloma Virus testing
• Human Immunodeficiency Virus testing
• Chancroid testing

MARKET BY LOCATION OF TESTING

Laboratory Testing

• Commercial/Private labs
• Public Health Labs

Point-of-Care (PoC) testing

MARKET BY TESTING DEVICES

Laboratory Devices: Instruments and systems

• Thermal Cyclers - PCR (News - Alert)
• Lateral Flow Readers - Immunochromatographic assays
• Flow Cytometers
• Differential Light Scattering machines
• Absorbance microplate reader - Enzyme Linked Immunosorbent Assay (ELISA)

POC testing Devices: Various diagnostic kits

• Phone (News - Alert) chips (microfluidics + ICT)
• Portable / bench top / rapid diagnostic kits

Companies Mentioned

• Abbott Laboratories
• Affymetrix, Inc.
• Alere, Inc.
• Becton Dickinson & Company
• BioMerieux
• Cepheid, Inc.
• Danaher (News - Alert) Corporation
• DiaSorin
• Hologic, Inc.
• Roche Diagnostics

For more information visit http://www.researchandmarkets.com/research/rkvk3q/global_sexually.

[ Back To TMCnet.com's Homepage ]